Percutaneous triamcinolone injection for upper eyelid retraction in thyroid eye disease
PurposeTo evaluate percutaneous triamcinolone (TA) injection efficacy in treating upper eyelid retraction (UER) for Australian thyroid eye disease (TED) patients.MethodsWe conducted a retrospective analysis across 8 years and multiple diverse Australian centres identified UER patients who received T...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-05-01
|
Series: | Frontiers in Ophthalmology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fopht.2024.1388197/full |